MethodsReader 04191 · Member profile

Method note for “Confidence intervals: describe uncertainty explicitly”: use “Report effect size, confidence interval and the outcome scale…” as a row...

State the study design and what was actually measured before discussing the proposed mechanism. Keep speculation explicitly labelled and avoid transla...

Clarification for “Clinical questions in an archive discussion”: the point beginning “Explain the study’s scope and limitations without…” belongs to t...

Case 21 — Exploratory subgroup analysis: keep the label visible Limit of the answer in “Exploratory subgroup analysis: keep the label visible”: “State...

Case 23 — Exploratory subgroup analysis: keep the label visible Limit of the answer in “Exploratory subgroup analysis: keep the label visible”: “State...

Case 29 — Reading a preclinical paper: what belongs beside the abstract? · source wording exercise Correction note for “Reading a preclinical paper: w...

If the source is not accessible, label the revision pending verification. An unavailable document is not a reason to invent its contents.

Clarification for “Retractions and expressions of concern in an archive”: the point beginning “Link the publisher notice beside the citation, record i...

A human-benefit claim needs appropriate human evidence. This preclinical note should describe its model and translation limits rather than suggesting ...